Cancer research, Big Pharma, ketolorac and other ‘financial orphans’

From ‘Pro-Publica, Journalism in the Public Interest’, comes another ‘must-read’:

MIA In The War On Cancer: Where Are The Low-Cost Treatments?

“Big Pharma’s focus on blockbuster cancer drugs squeezes out research into potential treatments that are more affordable.

“What is scientific and sexy is driven by what can be monetized” – along with fresh understanding on how tumours grow, plus fresh thinking on potential cancer treatments and ways to deliver them.

by Jake Bernstein
ProPublica, April 23, 2014,


About bmitzi

Medical writer, author, artist. Cancer campaigner. Aiming always to improve health services and bring compassion into health care.
This entry was posted in Campaigns, clinical trials, Compassion in healthcare, healthcare modernisation, patient safety, rarer and uncommon cancers and tagged , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s